Our Patient Centred Outcomes team conducts a Delphi panel with expert UK Endocrinologists

We were delighted that our pH Associates’ Patient Centred Outcomes team successfully brought together expert UK endocrinologists and conducted a Delphi panel. This work was the first step to understanding the characteristics considered ‘important’ by UK hypoparathyroidism experts for defining patients with chronic hypoparathyroidism. The results of the panel were recently presented at the Society…

Is your patient centred outcome (PCO) work truly patient centred?

At pH Associates we have worked successfully in collaboration with patient organisations across a number of different disease areas, working together throughout study development, rollout and publication. A recent document, published by European Federation of Pharmaceutical Industries and Associations (EFPIA) called “Working together with patient groups”, has sparked our interest. This document has been designed…

Noma Khumalo

pH Associates welcomes Noma Khumalo to the Project Management Team

Noma Khumalo is a Project Manager with experience conducting research in Real World Evidence studies and is skilled in undertaking set up activities through to study closure. Prior to joining pH Associates, Noma worked as an Observational Research Specialist in the CRO industry for several years where she supported and undertook feasibility, contract negotiation, obtaining…

World Antibiotic Awareness Week, 13-19 November 2017

World Antibiotic Awareness Week has been organised by the World Health Organisation (WHO) to encourage the effective use of antibiotics and raise awareness of global antibiotic resistance. It also aims to promote best practice among health care workers, policy makers and the general public, with this year’s theme being to ‘Handle Antibiotics with Care’. WHO…

ISPOR accepts 15 posters from pH Associates & OPEN Access Consulting!

pH Associates audit the use of real world data in recent NICE submissions

  The use of real world data in NICE decision-making Many countries have their own healthcare bodies dedicated to the systematic evaluation of new technologies, in order to provide recommendations as to their effectiveness and whether they should be financed or reimbursed by the healthcare system in that particular region. In England and Wales, The…